AT&T cut its dividend in 2022, and its stock performance has remained flat since. Verizon has increased its dividend for 19 consecutive years, but the stock has struggled in the past five years.
Visa and Mastercard Settle ATM Fee Lawsuit for $167 Million — Negative
MA PYMNTS — December 21, 2025Visa and Mastercard will reportedly pay $167.5 million to settle a long-running ATM fee lawsuit. That's according to a report Friday (Dec. 19) from Reuters, citing court documents in a case that had accused the payment giants of conspiring to artificially boost ATM access fees.
iRobot founder says company's bankruptcy revealed a new kind of competitor: 'The Chinese fast follower' — Negative
IRBT Business Insider — December 21, 2025iRobot filed for bankruptcy and will be acquired by Picea Robotics, a Chinese company. Founder Colin Angle said iRobot faced rising competition from Chinese robotics firms.
Prediction markets are ‘best we've got' for forecasting, Robinhood CEO says — Positive
HOOD Fox Business — December 21, 2025Robinhood Markets CEO Vlad Tenev explains how prediction markets have become the ‘fastest growing business of all time' and discusses their future on ‘Making Money.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #makingmoney #robinhood #vladtenev #predictionmarkets #markets #stocks #finance #business #economy #trading #forecasting #tech #innovation #growth #analysis
VOO vs. QQQ: Is S&P 500 Stability or Tech-Focused Growth the Better Choice for Investors? — Neutral
QQQ VOO The Motley Fool — December 21, 2025VOO charges much lower fees and offers a higher dividend yield compared to QQQ. QQQ has delivered stronger five-year growth but with higher volatility and a deeper drawdown.
VYM vs. FDVV: How These Popular Dividend ETFs Stack Up on Yield, Costs, and Risk — Positive
FDVV VYM The Motley Fool — December 21, 2025VYM costs less and holds a much broader basket of stocks than FDVV. FDVV delivers a higher dividend yield and is more concentrated in technology.
Samsung Biologics to buy U.S. drug production facility from GSK for $280 mln — Positive
GSK SSNLF Reuters — December 21, 2025South Korea's Samsung Biologics said on Monday its U.S. unit is buying a U.S. drug production facility from GSK for $280 million.
Could This AI Leader Be the Market's Best Performer Next Year? — Positive
MU The Motley Fool — December 21, 2025Micron just reported another strong quarter of sales and earnings growth. The company benefits from increasing demand for its DRAM memory.
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK — Neutral
GSK PRNewsWire — December 21, 2025Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional investments planned to expand the site's capacity (currently at 60,000 liters of drug substance) and capabilities to support growing manufacturing programs Underscores Samsung Biologics' long-term dedication to the U.S. biopharmaceutical industry and supply chain INCHEON, South Korea, ROCKVILLE, Md. and LONDON , Dec. 21, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human Genome Sciences from GSK …
Alphabet vs. Amazon: Which Stock Will Outperform in 2026? — Positive
AMZN GOOG GOOGL The Motley Fool — December 21, 2025Alphabet was able to change investor perception in 2025, leading to huge gains in the stock. Amazon has the same opportunity to do that in 2026.
U.S. Coast Guard Chasing Another Tanker Involved in Shipping Venezuela Oil — Negative
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP WSJ — December 21, 2025The operation comes after the boarding of two other ships this month as the administration carries out Trump's order to blockade Venezuela's oil shipments
Is LULU Stock a Buy After the CEO Announced His Resignation? — Negative
LULU The Motley Fool — December 21, 2025Lululemon stock is down more than 40% in the past five years. The brand's founder and former CEO, Chip Wilson, has been outspoken in his criticisms of company leadership and the board of directors.
VOO vs. VOOG: Is S&P 500 Diversification or Tech-Focused Growth the Better Choice for Investors? — Negative
VOO VOOG The Motley Fool — December 21, 2025VOOG has delivered higher one-year and five-year total returns, but with deeper drawdowns and more volatility than VOO. VOO is broader, more diversified, and offers a higher dividend yield at a lower expense ratio.
TQQQ and SSO Aim for Above-Average Returns, But There's a Clear Winner for Investors — Positive
SSO TQQQ The Motley Fool — December 21, 2025TQQQ charges a slightly lower expense ratio, but it carries far more risk than SSO. TQQQ has delivered a marginally stronger one-year return, while also experiencing a significantly deeper five-year drawdown.
Oracle's (ORCL +6.63%) stock price is falling, and investors are curious about the causes.
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions — Neutral
TLX GlobeNewsWire — December 21, 2025MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides a precision medicine portfolio update in relation to:
2 Monster Stocks to Hold for the Next 5 Years — Positive
BROS NVDA The Motley Fool — December 21, 2025Nvidia has created a wide moat and is poised to continue to be one of the biggest AI winners over the next five years. Dutch Bros is one of the best growth stories in the consumer space.
Costco (COST 0.23%) stock is experiencing a rare underperformance in 2025.
QLD vs. SPXL: Is Tech-Heavy Growth or S&P 500 Diversification Better for Investors? — Neutral
QLD SPXL The Motley Fool — December 21, 2025QLD has delivered a marginally higher one-year total return than SPXL, but both funds exhibit similar extreme drawdown risk. SPXL holds far more stocks, while QLD concentrates heavily in technology with just 101 positions.